AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI Drug Target Platform Puts Prediction and Benchmarking in the Same Loop
A new AI drug target platform pairs prediction with benchmarking to improve early discovery, aiming to make model outputs more scientifically reliable. The design reflects a growing realization that AI needs built-in validation, not just better predictions.
AI in Drug Discovery Is Now a $160 Billion Story, but the Real Market Is Still Being Built
A new forecast pegs the AI drug-discovery market at $160.49 billion by 2035, reflecting intense investor interest in the space. But forecasts this large also reveal how much of the market remains aspirational rather than proven.
AI in Drug Development Is Moving From Storytelling to Procurement Logic
Recent coverage of AI-led R&D partnerships suggests pharmaceutical companies are increasingly evaluating AI through procurement logic: cost, pipeline fit, and expected program output. That shift is a sign of maturation, but it also raises the bar for platform companies trying to sell into biopharma.
Insilico Pitches a New AI Agent Era for Drug Discovery
Insilico Medicine has introduced a new AI agent aimed at accelerating drug discovery workflows, extending the industry’s shift from standalone models toward more autonomous research systems. The move matters less as a product launch in isolation than as another sign that biopharma now wants AI that can coordinate tasks across target identification, design, and decision support.
Latent-Y’s Autonomous Drug-Design Agent Shows How Fast the Industry Is Moving Toward Full-Loop Systems
Business Wire’s announcement of Latent-Y as an autonomous AI agent for large-scale drug design adds to a growing wave of systems that aim to run more of the discovery loop with minimal human intervention. The launch is notable not because autonomy is new rhetoric, but because multiple companies are now converging on the same product form: AI as an active research operator rather than a passive prediction engine.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.